Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Creams: SOP for Testing Active Ingredient Content in Creams – V 2.0

Posted on By

Creams: SOP for Testing Active Ingredient Content in Creams – V 2.0

Standard Operating Procedure for Testing Active Ingredient Content in Creams

Department Creams
SOP No. SOP/CRM/132/2025
Supersedes SOP/CRM/132/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to define the procedure for testing the active ingredient content in cream formulations. Ensuring the correct amount of active ingredients is critical for the efficacy of the product. This SOP outlines the methods to ensure that the active ingredient content meets the specified levels as per formulation requirements.

2. Scope

This SOP applies to all cream formulations produced in the facility. It includes procedures for sampling, testing, and quantifying the active ingredient content in creams at different stages of production and before final release.

3. Responsibilities

  • Production Team: Responsible for providing representative samples of cream formulations for active ingredient content testing.
  • Quality Control (QC) Team: Responsible for performing the testing of active ingredients using validated methods and ensuring results meet the required specifications.
  • Quality Assurance (QA) Team: Responsible for reviewing and approving the test results to ensure the active ingredient content complies with regulatory and internal specifications.

4. Accountability

The

QC Manager is accountable for ensuring that active ingredient testing is carried out accurately and in accordance with this SOP. The Production Supervisor is responsible for ensuring that samples are collected from the correct production stages. The QA Manager ensures the integrity and compliance of test results with regulatory requirements.

See also  Creams: SOP for Operating Cream-Filling Machines - V 2.0

5. Procedure

5.1 Pre-Test Preparation

  1. Ensure that all necessary equipment for active ingredient content testing is available, including analytical balances, HPLC (High-Performance Liquid Chromatography) system, and reagents for sample preparation.
  2. Ensure that the HPLC system is calibrated and operating correctly, following the manufacturer’s instructions for validation.
  3. Review the batch record to identify the appropriate sampling points for active ingredient testing, typically post-manufacturing and prior to packaging.

5.2 Sample Collection

  1. Collect representative samples of the cream formulation from the batch at the designated sampling points. The sample size should be adequate for testing and should be free from contamination.
  2. Label the sample with the batch number, sample ID, sampling date, and sampling point to ensure traceability during testing.
  3. Ensure that the sample is homogenous, and take precautions to avoid cross-contamination when handling the sample.

5.3 Active Ingredient Testing Procedure

  1. Prepare the sample by dissolving the cream formulation in a suitable solvent to extract the active ingredient. This may include using solvents such as ethanol or methanol depending on the active ingredient.
  2. Filter the sample to remove any insoluble material, ensuring that only the active ingredient in solution is measured.
  3. Perform the active ingredient quantification using a validated method such as:
    • High-Performance Liquid Chromatography (HPLC): Use the appropriate HPLC method and column for the active ingredient being tested. Ensure that the solvent, flow rate, and detector are set according to the test specifications.
    • UV Spectrophotometry: If applicable, use UV spectrophotometry for the quantification of active ingredients that absorb light at a specific wavelength.
    • Titration: If required, use a suitable titration method to quantify the active ingredient, based on its chemical properties.
  4. Record the concentration of the active ingredient in the sample and compare it with the specification for the product. Ensure that the results are reproducible and accurate by performing the test in triplicate if necessary.
See also  Creams: SOP for Inline Sampling during Cream Manufacturing - V 2.0

5.4 Interpretation of Results

  1. Compare the test results with the product specifications for the active ingredient content. The active ingredient concentration should be within the acceptable range defined by the formulation requirements and regulatory guidelines.
  2. If the active ingredient content falls outside the acceptable range, mark the test as “Fail.” Investigate the cause of the deviation and review the formulation and production process for any potential errors.
  3. If the test results meet the required specifications, mark the test as “Pass” in the Active Ingredient Testing Log (Annexure-1) and proceed with the next stage of production or release.

5.5 Post-Test Activities

  1. Record all test results, including batch number, sample ID, active ingredient content, and any corrective actions taken, in the Active Ingredient Testing Log (Annexure-1).
  2. If the active ingredient content does not meet specifications, initiate corrective actions, such as reviewing raw material quality, formulation adjustments, or process optimization, and re-test the sample.
  3. Submit the test results for review and approval by the QA team to ensure compliance with regulatory and internal standards before product release.

5.6 Documentation and Record-Keeping

  1. Ensure that all records related to active ingredient content testing are complete, accurate, and securely stored. This includes the Active Ingredient Testing Log (Annexure-1) and the Deviation Log (Annexure-2) for failed tests.
  2. Retain all records for a minimum of two years or as required by regulatory guidelines.
  3. Ensure that records are reviewed and approved by the Quality Assurance team to verify compliance with GMP standards and regulatory requirements.
See also  Creams: SOP for High-Shear Mixing in Cream Manufacturing - V 2.0

6. Abbreviations

  • GMP: Good Manufacturing Practices
  • QC: Quality Control
  • QA: Quality Assurance
  • PPE: Personal Protective Equipment
  • HPLC: High-Performance Liquid Chromatography

7. Documents

  1. Annexure-1: Active Ingredient Testing Log
  2. Annexure-2: Deviation Log

8. References

  • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
  • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • Pharmacopeial Monographs for Active Ingredient Testing

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Active Ingredient Testing Log

Batch Number Sample ID Sampling Date Active Ingredient Content (%) Operator
12345 S-001 21/01/2026 5% John Doe

Annexure-2: Deviation Log

Deviation Date Batch Number Deviation Description Corrective Action Taken Operator
21/01/2026 12345 Low active ingredient content Adjusted formulation, re-tested Jane Smith

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/03/2024 1.0 Initial Version New SOP Creation QA Head
01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
Creams V 2.0 Tags:Batch record documentation for creams, Change control procedures for cream manufacturing, Cleaning and sanitization SOPs in creams production, Complaint handling SOPs in creams production, Continuous improvement SOPs for cream manufacturing, Cream manufacturing process guidelines, Creams production documentation practices, Deviation handling SOPs in creams production, Employee training SOPs in creams manufacturing, Environmental monitoring SOPs in creams manufacturing, Equipment calibration SOPs for cream manufacturing, GMP compliance in creams production, Internal audit procedures in creams production, Packaging and labeling SOPs for creams, Pharmaceutical SOPs, Product quality review procedures for creams, Product release criteria SOPs for creams, Quality control SOPs for creams, ream manufacturing SOP, Regulatory requirements for cream production SOPs, Risk management SOPs in creams manufacturing, Stability testing SOPs for cream products, Standard operating procedures for skincare products, Supplier qualification SOPs for cream ingredients, Validation protocols for cream production processes

Post navigation

Previous Post: Elixir Department: SOP for Calibration of Dispensing Balances – V 2.0
Next Post: BA-BE Studies: SOP for Volunteer Identification and Screening Logs – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version